

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 4.69947293 |
| 2 | ER overload response (GO:0006983) | 4.05529776 |
| 3 | establishment of nucleus localization (GO:0040023) | 3.73912282 |
| 4 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.71308833 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.65970240 |
| 6 | endocrine pancreas development (GO:0031018) | 3.57718008 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 3.50596089 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 3.50596089 |
| 9 | synaptic vesicle maturation (GO:0016188) | 3.40461368 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28975366 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 3.26793694 |
| 12 | type B pancreatic cell development (GO:0003323) | 3.24938635 |
| 13 | sequestering of metal ion (GO:0051238) | 3.24451213 |
| 14 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.20781847 |
| 15 | regulation of ARF protein signal transduction (GO:0032012) | 3.19959416 |
| 16 | olfactory bulb development (GO:0021772) | 3.09090439 |
| 17 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.06443642 |
| 18 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.06443642 |
| 19 | cell differentiation involved in metanephros development (GO:0072202) | 3.03554492 |
| 20 | positive regulation of fibroblast migration (GO:0010763) | 3.01691753 |
| 21 | cerebellar granule cell differentiation (GO:0021707) | 2.99062538 |
| 22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.98279394 |
| 23 | positive regulation of synapse maturation (GO:0090129) | 2.91759082 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.90350380 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.89895122 |
| 26 | somite development (GO:0061053) | 2.88770259 |
| 27 | cornea development in camera-type eye (GO:0061303) | 2.87359312 |
| 28 | glutamate secretion (GO:0014047) | 2.87042480 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 2.85600252 |
| 30 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.84806142 |
| 31 | ganglion development (GO:0061548) | 2.81891987 |
| 32 | auditory behavior (GO:0031223) | 2.80435744 |
| 33 | dendritic spine morphogenesis (GO:0060997) | 2.79628175 |
| 34 | potassium ion homeostasis (GO:0055075) | 2.79347637 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.78683922 |
| 36 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.76543250 |
| 37 | glandular epithelial cell development (GO:0002068) | 2.74865653 |
| 38 | positive regulation of glial cell differentiation (GO:0045687) | 2.74413998 |
| 39 | glandular epithelial cell differentiation (GO:0002067) | 2.73431783 |
| 40 | potassium ion import (GO:0010107) | 2.73225553 |
| 41 | sodium ion export (GO:0071436) | 2.72863901 |
| 42 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.72166979 |
| 43 | astrocyte differentiation (GO:0048708) | 2.69608165 |
| 44 | regulation of synapse maturation (GO:0090128) | 2.69348953 |
| 45 | cellular response to catecholamine stimulus (GO:0071870) | 2.67992517 |
| 46 | cellular response to monoamine stimulus (GO:0071868) | 2.67992517 |
| 47 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.67464824 |
| 48 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.65672171 |
| 49 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.65420347 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 2.65244394 |
| 51 | negative regulation of gluconeogenesis (GO:0045721) | 2.64288780 |
| 52 | positive regulation of Rap GTPase activity (GO:0032854) | 2.61875516 |
| 53 | response to peptidoglycan (GO:0032494) | 2.60463881 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.59956902 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59558381 |
| 56 | eye photoreceptor cell differentiation (GO:0001754) | 2.57392794 |
| 57 | photoreceptor cell differentiation (GO:0046530) | 2.57392794 |
| 58 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.57006408 |
| 59 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.56944397 |
| 60 | COPII vesicle coating (GO:0048208) | 2.54453226 |
| 61 | neurotransmitter secretion (GO:0007269) | 2.54391816 |
| 62 | activated T cell proliferation (GO:0050798) | 2.54353236 |
| 63 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.53678573 |
| 64 | regulation of male gonad development (GO:2000018) | 2.53178335 |
| 65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53094272 |
| 66 | amyloid precursor protein catabolic process (GO:0042987) | 2.51831248 |
| 67 | sequestering of actin monomers (GO:0042989) | 2.51519714 |
| 68 | peptide hormone processing (GO:0016486) | 2.50989321 |
| 69 | cellular response to nicotine (GO:0071316) | 2.49744115 |
| 70 | response to monoamine (GO:0071867) | 2.48228935 |
| 71 | response to catecholamine (GO:0071869) | 2.48228935 |
| 72 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.46975116 |
| 73 | exocrine pancreas development (GO:0031017) | 2.46423061 |
| 74 | locomotory exploration behavior (GO:0035641) | 2.46398584 |
| 75 | membrane protein ectodomain proteolysis (GO:0006509) | 2.45648641 |
| 76 | cellular response to epinephrine stimulus (GO:0071872) | 2.45062785 |
| 77 | limb bud formation (GO:0060174) | 2.44348814 |
| 78 | layer formation in cerebral cortex (GO:0021819) | 2.43843661 |
| 79 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.42517831 |
| 80 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.42350320 |
| 81 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.41262566 |
| 82 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.41221303 |
| 83 | cerebellar Purkinje cell layer development (GO:0021680) | 2.39425622 |
| 84 | detection of molecule of bacterial origin (GO:0032490) | 2.39258741 |
| 85 | negative regulation of glycogen metabolic process (GO:0070874) | 2.38978212 |
| 86 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.38943010 |
| 87 | metanephric mesenchyme development (GO:0072075) | 2.37091471 |
| 88 | detection of calcium ion (GO:0005513) | 2.37048195 |
| 89 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.36966657 |
| 90 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.36922081 |
| 91 | energy homeostasis (GO:0097009) | 2.36603265 |
| 92 | peripheral nervous system neuron development (GO:0048935) | 2.36073693 |
| 93 | regulation of respiratory system process (GO:0044065) | 2.36051228 |
| 94 | regulation of synaptic vesicle transport (GO:1902803) | 2.35940030 |
| 95 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.35397765 |
| 96 | cellular response to vitamin D (GO:0071305) | 2.34554525 |
| 97 | nucleus localization (GO:0051647) | 2.33982164 |
| 98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.33283711 |
| 99 | neural tube formation (GO:0001841) | 2.32417287 |
| 100 | mechanosensory behavior (GO:0007638) | 2.31728277 |
| 101 | respiratory burst (GO:0045730) | 2.31057585 |
| 102 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.29626499 |
| 103 | negative regulation of type 2 immune response (GO:0002829) | 2.29396226 |
| 104 | response to lipoprotein particle (GO:0055094) | 2.29091224 |
| 105 | histone H3-K4 trimethylation (GO:0080182) | 2.26714761 |
| 106 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.26702024 |
| 107 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.26484280 |
| 108 | regulation of chromatin binding (GO:0035561) | 2.26079619 |
| 109 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.25585325 |
| 110 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.25130252 |
| 111 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.24482213 |
| 112 | eosinophil chemotaxis (GO:0048245) | 2.24213690 |
| 113 | membrane protein proteolysis (GO:0033619) | 2.24033691 |
| 114 | urinary tract smooth muscle contraction (GO:0014848) | 2.23822659 |
| 115 | detection of other organism (GO:0098543) | 2.23106519 |
| 116 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.23040889 |
| 117 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.22662512 |
| 118 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.21046028 |
| 119 | neutrophil activation (GO:0042119) | 2.20321897 |
| 120 | positive regulation of protein dephosphorylation (GO:0035307) | 2.20016000 |
| 121 | postsynaptic membrane organization (GO:0001941) | 2.19980721 |
| 122 | positive regulation of dendritic spine development (GO:0060999) | 2.19508257 |
| 123 | regulation of extracellular matrix disassembly (GO:0010715) | 2.19458864 |
| 124 | amyloid precursor protein metabolic process (GO:0042982) | 2.18009519 |
| 125 | axonal fasciculation (GO:0007413) | 2.17786308 |
| 126 | mesenchymal cell differentiation (GO:0048762) | 2.17387838 |
| 127 | sex determination (GO:0007530) | 2.17236995 |
| 128 | regulation of Rap GTPase activity (GO:0032317) | 2.17144276 |
| 129 | androgen biosynthetic process (GO:0006702) | 2.17043517 |
| 130 | granulocyte activation (GO:0036230) | 2.16229092 |
| 131 | nucleoside diphosphate catabolic process (GO:0009134) | 2.15683319 |
| 132 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.15527282 |
| 133 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.15046479 |
| 134 | centriole replication (GO:0007099) | 2.14419316 |
| 135 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.14387491 |
| 136 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.13697752 |
| 137 | insulin secretion (GO:0030073) | 2.13489830 |
| 138 | L-amino acid import (GO:0043092) | 2.12782738 |
| 139 | suckling behavior (GO:0001967) | 2.12020876 |
| 140 | negative regulation of glucose transport (GO:0010829) | 2.11732495 |
| 141 | kidney mesenchyme development (GO:0072074) | 2.11002858 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.10778689 |
| 143 | central nervous system myelination (GO:0022010) | 2.10663176 |
| 144 | axon ensheathment in central nervous system (GO:0032291) | 2.10663176 |
| 145 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.10294415 |
| 146 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.10041601 |
| 147 | negative regulation of glucose import (GO:0046325) | 2.09760130 |
| 148 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.08974329 |
| 149 | response to parathyroid hormone (GO:0071107) | 2.08823149 |
| 150 | positive regulation by symbiont of host defense response (GO:0052509) | 2.08719303 |
| 151 | modulation by symbiont of host defense response (GO:0052031) | 2.08719303 |
| 152 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.08719303 |
| 153 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.08719303 |
| 154 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.08719303 |
| 155 | modulation by symbiont of host immune response (GO:0052553) | 2.08719303 |
| 156 | negative regulation of JUN kinase activity (GO:0043508) | 2.08425903 |
| 157 | regulation of synapse structural plasticity (GO:0051823) | 2.08395066 |
| 158 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.08046236 |
| 159 | regulation of vitamin metabolic process (GO:0030656) | 2.07995001 |
| 160 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.07974350 |
| 161 | regulation of glomerulus development (GO:0090192) | 2.07470416 |
| 162 | dopamine receptor signaling pathway (GO:0007212) | 2.05513505 |
| 163 | regulation of respiratory gaseous exchange (GO:0043576) | 2.05363761 |
| 164 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.05282334 |
| 165 | neural crest cell development (GO:0014032) | 2.05210344 |
| 166 | embryonic epithelial tube formation (GO:0001838) | 2.02754176 |
| 167 | viral protein processing (GO:0019082) | 2.02720410 |
| 168 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.02687866 |
| 169 | negative regulation of catenin import into nucleus (GO:0035414) | 2.02472858 |
| 170 | activation of protein kinase A activity (GO:0034199) | 2.02059305 |
| 171 | cell communication by electrical coupling (GO:0010644) | 2.01635708 |
| 172 | cellular sodium ion homeostasis (GO:0006883) | 2.01440214 |
| 173 | superoxide anion generation (GO:0042554) | 2.00568236 |
| 174 | response to epinephrine (GO:0071871) | 2.00379538 |
| 175 | neuron remodeling (GO:0016322) | 2.00195941 |
| 176 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.99985435 |
| 177 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 1.99595392 |
| 178 | peptidyl-threonine phosphorylation (GO:0018107) | 1.99460617 |
| 179 | cell differentiation in hindbrain (GO:0021533) | 1.99155730 |
| 180 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 1.99144791 |
| 181 | regulation of ARF GTPase activity (GO:0032312) | 1.99067615 |
| 182 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 1.99045974 |
| 183 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.97798385 |
| 184 | epithelial cell fate commitment (GO:0072148) | 1.97329532 |
| 185 | response to auditory stimulus (GO:0010996) | 1.95436509 |
| 186 | positive regulation of glycogen biosynthetic process (GO:0045725) | 1.95338285 |
| 187 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 1.95204928 |
| 188 | exploration behavior (GO:0035640) | 1.94814777 |
| 189 | positive regulation of CREB transcription factor activity (GO:0032793) | 1.94554362 |
| 190 | positive regulation of membrane potential (GO:0045838) | 1.93674004 |
| 191 | neuron recognition (GO:0008038) | 1.93477475 |
| 192 | synaptic vesicle endocytosis (GO:0048488) | 1.93281510 |
| 193 | cerebellar Purkinje cell differentiation (GO:0021702) | 1.92376306 |
| 194 | negative regulation of cAMP-mediated signaling (GO:0043951) | 1.92362799 |
| 195 | cellular response to fluid shear stress (GO:0071498) | 1.91861232 |
| 196 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 1.91811118 |
| 197 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.91381751 |
| 198 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.90865344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.59267342 |
| 2 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.25397652 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.18906091 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14141936 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.14043128 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13901430 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.12158084 |
| 8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.11558482 |
| 9 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.92965263 |
| 10 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.92039699 |
| 11 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.90020154 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87461377 |
| 13 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.79791068 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79723665 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.75686172 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73954602 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.73142701 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.67403280 |
| 19 | KDM2B_26808549_Chip-Seq_K562_Human | 1.65888557 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.65836676 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.65571830 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65564775 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64466294 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62143813 |
| 25 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58940361 |
| 26 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.56536616 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55984108 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.55894949 |
| 29 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54535390 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53184338 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.51869865 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50352064 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49798428 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.49344217 |
| 35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.48545214 |
| 36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.48545214 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45509774 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45201123 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44051459 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.42156998 |
| 41 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.41535579 |
| 42 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40670649 |
| 43 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40670649 |
| 44 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40288076 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.40214448 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40005990 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.38329307 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37877263 |
| 49 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.37503165 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36948091 |
| 51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.36854884 |
| 52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.36519633 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36132233 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35071560 |
| 55 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.34579366 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34402679 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31911445 |
| 58 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29624840 |
| 59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29140930 |
| 60 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.28562792 |
| 61 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28193809 |
| 62 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27600400 |
| 63 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27310028 |
| 64 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25858113 |
| 65 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.25506514 |
| 66 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.25116631 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23742953 |
| 68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.23692678 |
| 69 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.22873562 |
| 70 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22755315 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21777202 |
| 72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21364918 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19007604 |
| 74 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18448078 |
| 75 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18377019 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18245533 |
| 77 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17891565 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17595631 |
| 79 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16944883 |
| 80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16911284 |
| 81 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16878417 |
| 82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16571318 |
| 83 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16423473 |
| 84 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.16370890 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15141468 |
| 86 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13898714 |
| 87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13890722 |
| 88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13690366 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11390626 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10097975 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09519782 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09229565 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08900301 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08536037 |
| 95 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.07596454 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07561533 |
| 97 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07509227 |
| 98 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06941004 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06056515 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05499827 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04386067 |
| 102 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03575232 |
| 103 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01889494 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00969538 |
| 105 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.00922283 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00821531 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00614093 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00361366 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00111679 |
| 110 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99625609 |
| 111 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.99322953 |
| 112 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98842366 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 0.98707421 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98582616 |
| 115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98486694 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97986565 |
| 117 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96500495 |
| 118 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95862168 |
| 119 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95058029 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94580967 |
| 121 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94314350 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94234770 |
| 123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93859889 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93640437 |
| 125 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93567505 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93544265 |
| 127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93380820 |
| 128 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93244960 |
| 129 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93185828 |
| 130 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92897504 |
| 131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92720912 |
| 132 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92251170 |
| 133 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91212739 |
| 134 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90835926 |
| 135 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90807168 |
| 136 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90445255 |
| 137 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90350472 |
| 138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89771219 |
| 139 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89499138 |
| 140 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88860893 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88690764 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88093909 |
| 143 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87477115 |
| 144 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.86424078 |
| 145 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86246104 |
| 146 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85316784 |
| 147 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83427356 |
| 148 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83095430 |
| 149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82268226 |
| 150 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81216091 |
| 151 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81206155 |
| 152 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.80046103 |
| 153 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.78484676 |
| 154 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.78484676 |
| 155 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.78237576 |
| 156 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77771882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.82689831 |
| 2 | MP0003195_calcinosis | 3.65987204 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.50358468 |
| 4 | MP0008789_abnormal_olfactory_epithelium | 3.48510583 |
| 5 | MP0003787_abnormal_imprinting | 2.69255294 |
| 6 | MP0006054_spinal_hemorrhage | 2.62491494 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.53584393 |
| 8 | MP0005499_abnormal_olfactory_system | 2.48333092 |
| 9 | MP0005394_taste/olfaction_phenotype | 2.48333092 |
| 10 | MP0002693_abnormal_pancreas_physiology | 2.44435071 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.44192920 |
| 12 | MP0004043_abnormal_pH_regulation | 2.42794910 |
| 13 | MP0000678_abnormal_parathyroid_gland | 2.39666511 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.36192992 |
| 15 | MP0004270_analgesia | 2.27468676 |
| 16 | MP0001958_emphysema | 2.24113663 |
| 17 | MP0003724_increased_susceptibility_to | 2.23767589 |
| 18 | MP0010386_abnormal_urinary_bladder | 2.20746918 |
| 19 | MP0001944_abnormal_pancreas_morphology | 2.13721966 |
| 20 | MP0002064_seizures | 2.10718847 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.06851330 |
| 22 | MP0003879_abnormal_hair_cell | 1.99179972 |
| 23 | MP0005379_endocrine/exocrine_gland_phen | 1.89848303 |
| 24 | MP0005257_abnormal_intraocular_pressure | 1.89769605 |
| 25 | MP0002896_abnormal_bone_mineralization | 1.89656100 |
| 26 | MP0004130_abnormal_muscle_cell | 1.87608450 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.87361720 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.84291911 |
| 29 | MP0001502_abnormal_circadian_rhythm | 1.83608548 |
| 30 | MP0008569_lethality_at_weaning | 1.80104663 |
| 31 | MP0004885_abnormal_endolymph | 1.77816660 |
| 32 | MP0003880_abnormal_central_pattern | 1.69561598 |
| 33 | MP0001501_abnormal_sleep_pattern | 1.69195240 |
| 34 | MP0003279_aneurysm | 1.69047344 |
| 35 | MP0009250_abnormal_appendicular_skeleto | 1.67457700 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.65938342 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.62302256 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.61624260 |
| 39 | MP0009745_abnormal_behavioral_response | 1.59604355 |
| 40 | MP0003123_paternal_imprinting | 1.57753781 |
| 41 | MP0005220_abnormal_exocrine_pancreas | 1.57144886 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.56656903 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.55144803 |
| 44 | MP0002272_abnormal_nervous_system | 1.54691834 |
| 45 | MP0009046_muscle_twitch | 1.53673098 |
| 46 | MP0000013_abnormal_adipose_tissue | 1.51707083 |
| 47 | MP0003122_maternal_imprinting | 1.49979280 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.41999413 |
| 49 | MP0001486_abnormal_startle_reflex | 1.41536542 |
| 50 | MP0000613_abnormal_salivary_gland | 1.40775218 |
| 51 | MP0003690_abnormal_glial_cell | 1.40520414 |
| 52 | MP0002572_abnormal_emotion/affect_behav | 1.39958494 |
| 53 | MP0002108_abnormal_muscle_morphology | 1.38745887 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.37811276 |
| 55 | MP0004142_abnormal_muscle_tone | 1.36901762 |
| 56 | MP0002938_white_spotting | 1.35741669 |
| 57 | MP0003633_abnormal_nervous_system | 1.34692277 |
| 58 | MP0002009_preneoplasia | 1.30764988 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.30733808 |
| 60 | MP0003329_amyloid_beta_deposits | 1.29411074 |
| 61 | MP0002928_abnormal_bile_duct | 1.28225614 |
| 62 | MP0000778_abnormal_nervous_system | 1.27699417 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.27589536 |
| 64 | MP0000462_abnormal_digestive_system | 1.26290309 |
| 65 | MP0005409_darkened_coat_color | 1.23154636 |
| 66 | MP0001851_eye_inflammation | 1.21738103 |
| 67 | MP0004924_abnormal_behavior | 1.21616512 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.21616512 |
| 69 | MP0005275_abnormal_skin_tensile | 1.21038267 |
| 70 | MP0002734_abnormal_mechanical_nocicepti | 1.20968070 |
| 71 | MP0000566_synostosis | 1.20040512 |
| 72 | MP0003303_peritoneal_inflammation | 1.19373207 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.19245052 |
| 74 | MP0001970_abnormal_pain_threshold | 1.18826890 |
| 75 | MP0001879_abnormal_lymphatic_vessel | 1.18239741 |
| 76 | MP0000955_abnormal_spinal_cord | 1.17240351 |
| 77 | MP0002233_abnormal_nose_morphology | 1.17213856 |
| 78 | * MP0002249_abnormal_larynx_morphology | 1.14953695 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.14284465 |
| 80 | MP0003942_abnormal_urinary_system | 1.12983138 |
| 81 | MP0002419_abnormal_innate_immunity | 1.12253795 |
| 82 | MP0003795_abnormal_bone_structure | 1.11908943 |
| 83 | MP0002909_abnormal_adrenal_gland | 1.11881668 |
| 84 | MP0001270_distended_abdomen | 1.11401552 |
| 85 | MP0002971_abnormal_brown_adipose | 1.11118379 |
| 86 | MP0001346_abnormal_lacrimal_gland | 1.10679163 |
| 87 | MP0003385_abnormal_body_wall | 1.09448910 |
| 88 | MP0000538_abnormal_urinary_bladder | 1.09176954 |
| 89 | MP0005646_abnormal_pituitary_gland | 1.08848782 |
| 90 | MP0001835_abnormal_antigen_presentation | 1.08602470 |
| 91 | MP0003091_abnormal_cell_migration | 1.08224446 |
| 92 | MP0009785_altered_susceptibility_to | 1.07712709 |
| 93 | MP0005387_immune_system_phenotype | 1.07644000 |
| 94 | MP0001790_abnormal_immune_system | 1.07644000 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 1.05234018 |
| 96 | MP0002557_abnormal_social/conspecific_i | 1.04634846 |
| 97 | MP0005408_hypopigmentation | 1.04522261 |
| 98 | MP0000569_abnormal_digit_pigmentation | 1.02351782 |
| 99 | MP0005310_abnormal_salivary_gland | 1.01733692 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.99801123 |
| 101 | MP0005187_abnormal_penis_morphology | 0.99700442 |
| 102 | MP0000372_irregular_coat_pigmentation | 0.99419373 |
| 103 | MP0002735_abnormal_chemical_nociception | 0.99118396 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.99001743 |
| 105 | MP0001188_hyperpigmentation | 0.98600072 |
| 106 | MP0000920_abnormal_myelination | 0.98050916 |
| 107 | MP0002115_abnormal_skeleton_extremities | 0.96663414 |
| 108 | MP0000516_abnormal_urinary_system | 0.95491803 |
| 109 | MP0005367_renal/urinary_system_phenotyp | 0.95491803 |
| 110 | MP0000685_abnormal_immune_system | 0.95238012 |
| 111 | MP0003631_nervous_system_phenotype | 0.93346186 |
| 112 | MP0004381_abnormal_hair_follicle | 0.93246234 |
| 113 | MP0002733_abnormal_thermal_nociception | 0.92674383 |
| 114 | MP0002163_abnormal_gland_morphology | 0.92461655 |
| 115 | MP0000647_abnormal_sebaceous_gland | 0.92121997 |
| 116 | MP0002295_abnormal_pulmonary_circulatio | 0.91592735 |
| 117 | MP0002168_other_aberrant_phenotype | 0.91449829 |
| 118 | MP0003959_abnormal_lean_body | 0.90844618 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.90739938 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.89310356 |
| 121 | MP0004742_abnormal_vestibular_system | 0.89127366 |
| 122 | MP0001340_abnormal_eyelid_morphology | 0.88802726 |
| 123 | MP0005508_abnormal_skeleton_morphology | 0.88729962 |
| 124 | MP0001984_abnormal_olfaction | 0.88427093 |
| 125 | MP0002638_abnormal_pupillary_reflex | 0.88333043 |
| 126 | MP0002933_joint_inflammation | 0.88332605 |
| 127 | MP0002066_abnormal_motor_capabilities/c | 0.88037897 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.87492577 |
| 129 | MP0001177_atelectasis | 0.87280828 |
| 130 | MP0004811_abnormal_neuron_physiology | 0.86862451 |
| 131 | MP0001664_abnormal_digestion | 0.86696821 |
| 132 | MP0004510_myositis | 0.85435424 |
| 133 | MP0003436_decreased_susceptibility_to | 0.84958092 |
| 134 | MP0004145_abnormal_muscle_electrophysio | 0.84778415 |
| 135 | MP0002882_abnormal_neuron_morphology | 0.84568637 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.84116485 |
| 137 | MP0002184_abnormal_innervation | 0.84114723 |
| 138 | MP0003283_abnormal_digestive_organ | 0.83980001 |
| 139 | MP0005171_absent_coat_pigmentation | 0.83647151 |
| 140 | MP0000534_abnormal_ureter_morphology | 0.82889930 |
| 141 | MP0000015_abnormal_ear_pigmentation | 0.82660996 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.81992265 |
| 143 | MP0005390_skeleton_phenotype | 0.81971352 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.81658590 |
| 145 | MP0005388_respiratory_system_phenotype | 0.79570135 |
| 146 | MP0002133_abnormal_respiratory_system | 0.79570135 |
| 147 | MP0005535_abnormal_body_temperature | 0.79558293 |
| 148 | MP0000733_abnormal_muscle_development | 0.79333801 |
| 149 | MP0003045_fibrosis | 0.78952581 |
| 150 | MP0005025_abnormal_response_to | 0.78801826 |
| 151 | * MP0000163_abnormal_cartilage_morphology | 0.78543876 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.78505599 |
| 153 | MP0002109_abnormal_limb_morphology | 0.78073372 |
| 154 | MP0000470_abnormal_stomach_morphology | 0.77374432 |
| 155 | MP0008438_abnormal_cutaneous_collagen | 0.77364380 |
| 156 | MP0002113_abnormal_skeleton_development | 0.76919506 |
| 157 | * MP0002116_abnormal_craniofacial_bone | 0.76895738 |
| 158 | MP0005595_abnormal_vascular_smooth | 0.76723186 |
| 159 | MP0003937_abnormal_limbs/digits/tail_de | 0.76024764 |
| 160 | MP0001348_abnormal_lacrimal_gland | 0.75703243 |
| 161 | MP0009764_decreased_sensitivity_to | 0.75663052 |
| 162 | MP0006082_CNS_inflammation | 0.75596183 |
| 163 | * MP0003755_abnormal_palate_morphology | 0.75526545 |
| 164 | MP0000681_abnormal_thyroid_gland | 0.75414360 |
| 165 | MP0004134_abnormal_chest_morphology | 0.74984234 |
| 166 | MP0001299_abnormal_eye_distance/ | 0.74962155 |
| 167 | * MP0000049_abnormal_middle_ear | 0.74660559 |
| 168 | * MP0001943_abnormal_respiration | 0.73371774 |
| 169 | MP0005375_adipose_tissue_phenotype | 0.73306941 |
| 170 | MP0002098_abnormal_vibrissa_morphology | 0.73296825 |
| 171 | MP0003828_pulmonary_edema | 0.72898881 |
| 172 | MP0002060_abnormal_skin_morphology | 0.72180785 |
| 173 | MP0003634_abnormal_glial_cell | 0.71978868 |
| 174 | MP0003868_abnormal_feces_composition | 0.69078274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.17459530 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.76206483 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.75988098 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.72789796 |
| 5 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.49633363 |
| 6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.28167573 |
| 7 | Symptomatic seizures (HP:0011145) | 3.27102166 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.20971550 |
| 9 | Hypothermia (HP:0002045) | 3.20581183 |
| 10 | Hypoglycemic seizures (HP:0002173) | 3.09515854 |
| 11 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.02559855 |
| 12 | Hyperglycemia (HP:0003074) | 2.90750489 |
| 13 | Abnormal sex determination (HP:0012244) | 2.88727103 |
| 14 | Sex reversal (HP:0012245) | 2.88727103 |
| 15 | Papilledema (HP:0001085) | 2.88174017 |
| 16 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.74703188 |
| 17 | True hermaphroditism (HP:0010459) | 2.74604298 |
| 18 | Protrusio acetabuli (HP:0003179) | 2.72644248 |
| 19 | Congenital sensorineural hearing impairment (HP:0008527) | 2.63904211 |
| 20 | Prostate neoplasm (HP:0100787) | 2.62253326 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62121772 |
| 22 | Asymmetry of the thorax (HP:0001555) | 2.60243062 |
| 23 | Action tremor (HP:0002345) | 2.58214004 |
| 24 | Febrile seizures (HP:0002373) | 2.52428836 |
| 25 | Macroorchidism (HP:0000053) | 2.47452115 |
| 26 | Abnormality of binocular vision (HP:0011514) | 2.45503337 |
| 27 | Diplopia (HP:0000651) | 2.45503337 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.44477482 |
| 29 | Metaphyseal dysplasia (HP:0100255) | 2.42967486 |
| 30 | Annular pancreas (HP:0001734) | 2.41599252 |
| 31 | Overgrowth (HP:0001548) | 2.41502056 |
| 32 | Shallow orbits (HP:0000586) | 2.38410351 |
| 33 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.38386854 |
| 34 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.38386854 |
| 35 | Sleep apnea (HP:0010535) | 2.36931877 |
| 36 | Focal seizures (HP:0007359) | 2.36915452 |
| 37 | Unilateral renal agenesis (HP:0000122) | 2.36013147 |
| 38 | Hypercortisolism (HP:0001578) | 2.35871505 |
| 39 | Pancreatic fibrosis (HP:0100732) | 2.34075509 |
| 40 | Aortic aneurysm (HP:0004942) | 2.33365587 |
| 41 | Truncal ataxia (HP:0002078) | 2.33187372 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.31464415 |
| 43 | Hypokalemia (HP:0002900) | 2.31221273 |
| 44 | Progressive cerebellar ataxia (HP:0002073) | 2.31144000 |
| 45 | Abnormal eating behavior (HP:0100738) | 2.27234503 |
| 46 | Genetic anticipation (HP:0003743) | 2.25288493 |
| 47 | Lip pit (HP:0100267) | 2.23862696 |
| 48 | Blue irides (HP:0000635) | 2.23333647 |
| 49 | Neonatal short-limb short stature (HP:0008921) | 2.22095232 |
| 50 | Vascular tortuosity (HP:0004948) | 2.21016438 |
| 51 | Hyperparathyroidism (HP:0000843) | 2.20893058 |
| 52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20734167 |
| 53 | Bladder diverticulum (HP:0000015) | 2.20172362 |
| 54 | Gingivitis (HP:0000230) | 2.19027043 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.18815308 |
| 56 | Optic neuritis (HP:0100653) | 2.18815308 |
| 57 | Large for gestational age (HP:0001520) | 2.18759610 |
| 58 | Testicular neoplasm (HP:0010788) | 2.16857777 |
| 59 | Agitation (HP:0000713) | 2.16664138 |
| 60 | Occipital encephalocele (HP:0002085) | 2.13664901 |
| 61 | Hyperphosphatemia (HP:0002905) | 2.13254054 |
| 62 | Dysmetric saccades (HP:0000641) | 2.10805264 |
| 63 | Turricephaly (HP:0000262) | 2.10382319 |
| 64 | Epileptic encephalopathy (HP:0200134) | 2.09616010 |
| 65 | Ankle clonus (HP:0011448) | 2.09578179 |
| 66 | Cystic liver disease (HP:0006706) | 2.08908970 |
| 67 | Abnormality of the aortic arch (HP:0012303) | 2.08377115 |
| 68 | Enlarged penis (HP:0000040) | 2.07784574 |
| 69 | Cerebral inclusion bodies (HP:0100314) | 2.07682632 |
| 70 | Hypoglycemic coma (HP:0001325) | 2.06488831 |
| 71 | Difficulty running (HP:0009046) | 2.05570803 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 2.05172869 |
| 73 | Mitral regurgitation (HP:0001653) | 2.04307428 |
| 74 | Hyperacusis (HP:0010780) | 2.04194145 |
| 75 | Medial flaring of the eyebrow (HP:0010747) | 2.03470562 |
| 76 | Spinal cord lesions (HP:0100561) | 2.02709769 |
| 77 | Syringomyelia (HP:0003396) | 2.02709769 |
| 78 | Aneurysm (HP:0002617) | 2.01681890 |
| 79 | Xerostomia (HP:0000217) | 2.01630151 |
| 80 | Spinal canal stenosis (HP:0003416) | 2.01615719 |
| 81 | Focal motor seizures (HP:0011153) | 2.00636728 |
| 82 | Recurrent skin infections (HP:0001581) | 2.00357046 |
| 83 | Myokymia (HP:0002411) | 2.00313063 |
| 84 | Mucopolysacchariduria (HP:0008155) | 1.99912880 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99912880 |
| 86 | Thoracolumbar scoliosis (HP:0002944) | 1.97886044 |
| 87 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96625801 |
| 88 | Hemiparesis (HP:0001269) | 1.96210510 |
| 89 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.96002725 |
| 90 | Aortic dissection (HP:0002647) | 1.95510693 |
| 91 | Narrow palate (HP:0000189) | 1.94891239 |
| 92 | Bowel diverticulosis (HP:0005222) | 1.94631308 |
| 93 | Decreased circulating renin level (HP:0003351) | 1.93724743 |
| 94 | Enlarged kidneys (HP:0000105) | 1.91704861 |
| 95 | Genu recurvatum (HP:0002816) | 1.91085722 |
| 96 | Hypoventilation (HP:0002791) | 1.89869628 |
| 97 | Hemiplegia (HP:0002301) | 1.89564326 |
| 98 | Broad metatarsal (HP:0001783) | 1.88982725 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88370623 |
| 100 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.88064323 |
| 101 | Popliteal pterygium (HP:0009756) | 1.87914516 |
| 102 | Short middle phalanx of the 5th finger (HP:0004220) | 1.87891406 |
| 103 | Acne (HP:0001061) | 1.87401435 |
| 104 | Atonic seizures (HP:0010819) | 1.86376462 |
| 105 | Genital tract atresia (HP:0001827) | 1.85986236 |
| 106 | Absence seizures (HP:0002121) | 1.85478572 |
| 107 | Abnormal pancreas size (HP:0012094) | 1.85457924 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85074525 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85074525 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85074525 |
| 111 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.84725506 |
| 112 | Hypoplasia of the fovea (HP:0007750) | 1.84725506 |
| 113 | Submucous cleft hard palate (HP:0000176) | 1.84701056 |
| 114 | Orchitis (HP:0100796) | 1.84373415 |
| 115 | Palpebral edema (HP:0100540) | 1.84009339 |
| 116 | Hyperextensible skin (HP:0000974) | 1.83221238 |
| 117 | Cone-rod dystrophy (HP:0000548) | 1.82985517 |
| 118 | Metabolic alkalosis (HP:0200114) | 1.82229675 |
| 119 | Deep palmar crease (HP:0006191) | 1.82145814 |
| 120 | Type 1 muscle fiber predominance (HP:0003803) | 1.82120503 |
| 121 | Athetosis (HP:0002305) | 1.81503851 |
| 122 | Abnormality of the frontal sinuses (HP:0002687) | 1.81324128 |
| 123 | Abnormality of potassium homeostasis (HP:0011042) | 1.81200920 |
| 124 | Anosmia (HP:0000458) | 1.78770529 |
| 125 | Absent eyebrow (HP:0002223) | 1.77883993 |
| 126 | Osteomalacia (HP:0002749) | 1.77527446 |
| 127 | Arterial tortuosity (HP:0005116) | 1.77507856 |
| 128 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.76827163 |
| 129 | Hypoplasia of the iris (HP:0007676) | 1.76603852 |
| 130 | Megalencephaly (HP:0001355) | 1.76401249 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.75340362 |
| 132 | Mild short stature (HP:0003502) | 1.75292513 |
| 133 | Vacuolated lymphocytes (HP:0001922) | 1.74949952 |
| 134 | Broad-based gait (HP:0002136) | 1.73600989 |
| 135 | Growth hormone excess (HP:0000845) | 1.73290575 |
| 136 | Ocular albinism (HP:0001107) | 1.73160492 |
| 137 | Supernumerary nipples (HP:0002558) | 1.73113438 |
| 138 | Dislocated radial head (HP:0003083) | 1.73042200 |
| 139 | Laryngomalacia (HP:0001601) | 1.71962863 |
| 140 | Epileptiform EEG discharges (HP:0011182) | 1.71507222 |
| 141 | Wormian bones (HP:0002645) | 1.71440713 |
| 142 | Wide anterior fontanel (HP:0000260) | 1.71280479 |
| 143 | Spondylolisthesis (HP:0003302) | 1.69810760 |
| 144 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.69623591 |
| 145 | Bell-shaped thorax (HP:0001591) | 1.69512395 |
| 146 | Visceral angiomatosis (HP:0100761) | 1.69405746 |
| 147 | Lower limb asymmetry (HP:0100559) | 1.69378510 |
| 148 | Ventricular fibrillation (HP:0001663) | 1.69199708 |
| 149 | Exocrine pancreatic insufficiency (HP:0001738) | 1.68861382 |
| 150 | Thin bony cortex (HP:0002753) | 1.68411879 |
| 151 | Decreased central vision (HP:0007663) | 1.67881164 |
| 152 | Vaginal atresia (HP:0000148) | 1.67805902 |
| 153 | Abnormality of the parietal bone (HP:0002696) | 1.67617796 |
| 154 | Hypokalemic alkalosis (HP:0001949) | 1.66821316 |
| 155 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.66580180 |
| 156 | Neurofibrillary tangles (HP:0002185) | 1.66455657 |
| 157 | Thick nail (HP:0001805) | 1.66402852 |
| 158 | Striae distensae (HP:0001065) | 1.66389928 |
| 159 | Fragile skin (HP:0001030) | 1.66111904 |
| 160 | Molar tooth sign on MRI (HP:0002419) | 1.65988623 |
| 161 | Abnormality of midbrain morphology (HP:0002418) | 1.65988623 |
| 162 | Increased circulating renin level (HP:0000848) | 1.65379483 |
| 163 | Menstrual irregularities (HP:0000858) | 1.65093790 |
| 164 | Gait imbalance (HP:0002141) | 1.64456581 |
| 165 | Depression (HP:0000716) | 1.64452263 |
| 166 | Germ cell neoplasia (HP:0100728) | 1.63758903 |
| 167 | Torticollis (HP:0000473) | 1.63589059 |
| 168 | EEG with generalized epileptiform discharges (HP:0011198) | 1.63005361 |
| 169 | Truncal obesity (HP:0001956) | 1.62946826 |
| 170 | Male pseudohermaphroditism (HP:0000037) | 1.62810189 |
| 171 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.62741859 |
| 172 | Subaortic stenosis (HP:0001682) | 1.62741859 |
| 173 | Dysdiadochokinesis (HP:0002075) | 1.62518895 |
| 174 | Abnormality of macrophages (HP:0004311) | 1.62362182 |
| 175 | Mitral valve prolapse (HP:0001634) | 1.62158218 |
| 176 | Congenital hepatic fibrosis (HP:0002612) | 1.62063168 |
| 177 | Abnormality of renin-angiotensin system (HP:0000847) | 1.62006363 |
| 178 | Craniofacial hyperostosis (HP:0004493) | 1.61356597 |
| 179 | Congenital primary aphakia (HP:0007707) | 1.61176416 |
| 180 | Abnormality of the radial head (HP:0003995) | 1.61097678 |
| 181 | Impaired smooth pursuit (HP:0007772) | 1.60193377 |
| 182 | Cranial hyperostosis (HP:0004437) | 1.59729269 |
| 183 | Cupped ear (HP:0000378) | 1.59565632 |
| 184 | Peripheral hypomyelination (HP:0007182) | 1.59163788 |
| 185 | Round face (HP:0000311) | 1.59109816 |
| 186 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.58952330 |
| 187 | Sacral dimple (HP:0000960) | 1.58900029 |
| 188 | Abnormality of chloride homeostasis (HP:0011422) | 1.57951475 |
| 189 | Ulnar bowing (HP:0003031) | 1.57737059 |
| 190 | Vasculitis (HP:0002633) | 1.57701950 |
| 191 | Buphthalmos (HP:0000557) | 1.57630873 |
| 192 | Venous insufficiency (HP:0005293) | 1.57509345 |
| 193 | Obstructive lung disease (HP:0006536) | 1.57121403 |
| 194 | Premature rupture of membranes (HP:0001788) | 1.57011566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB3 | 4.62087695 |
| 2 | INSRR | 4.33384101 |
| 3 | BMPR2 | 3.71056422 |
| 4 | PRPF4B | 2.89308811 |
| 5 | MARK1 | 2.63953784 |
| 6 | TAOK3 | 2.58380891 |
| 7 | RIPK1 | 2.50884330 |
| 8 | IRAK4 | 2.33925426 |
| 9 | NTRK3 | 2.26807034 |
| 10 | MAPK15 | 2.25301694 |
| 11 | MAP3K14 | 2.23883331 |
| 12 | AKT3 | 2.22478934 |
| 13 | IRAK3 | 2.02715355 |
| 14 | TRIB3 | 1.99180758 |
| 15 | HIPK2 | 1.83072112 |
| 16 | WNK4 | 1.81833660 |
| 17 | BMPR1B | 1.73126405 |
| 18 | FRK | 1.68442805 |
| 19 | PAK6 | 1.67594655 |
| 20 | NUAK1 | 1.66756090 |
| 21 | TXK | 1.62531694 |
| 22 | SGK3 | 1.59292121 |
| 23 | MARK2 | 1.58326369 |
| 24 | EEF2K | 1.54561786 |
| 25 | FES | 1.53940578 |
| 26 | EPHB1 | 1.51466373 |
| 27 | MAP3K2 | 1.49898376 |
| 28 | IRAK1 | 1.49691579 |
| 29 | DAPK2 | 1.47157695 |
| 30 | EPHA3 | 1.43996367 |
| 31 | MST1R | 1.42036025 |
| 32 | KSR2 | 1.36518705 |
| 33 | JAK3 | 1.36402590 |
| 34 | CASK | 1.35255045 |
| 35 | ICK | 1.34516813 |
| 36 | PASK | 1.33579046 |
| 37 | MET | 1.32591759 |
| 38 | STK38 | 1.27419978 |
| 39 | PLK4 | 1.25994875 |
| 40 | RIPK4 | 1.24263994 |
| 41 | STK39 | 1.23692250 |
| 42 | NLK | 1.23162822 |
| 43 | WNK1 | 1.20235351 |
| 44 | TYRO3 | 1.18657282 |
| 45 | MAPK12 | 1.14679083 |
| 46 | NEK9 | 1.14551043 |
| 47 | IKBKE | 1.12721978 |
| 48 | CAMKK1 | 1.12585717 |
| 49 | SIK3 | 1.10348748 |
| 50 | PDGFRA | 1.08410860 |
| 51 | MAP3K9 | 1.08122208 |
| 52 | RPS6KA2 | 1.03955327 |
| 53 | CHUK | 1.03464017 |
| 54 | IRAK2 | 1.02345374 |
| 55 | TAOK1 | 1.01533114 |
| 56 | PHKG2 | 0.99004071 |
| 57 | PHKG1 | 0.99004071 |
| 58 | MAP3K7 | 0.98529199 |
| 59 | DYRK1B | 0.96753321 |
| 60 | MAP3K13 | 0.92163334 |
| 61 | MAP2K2 | 0.91180377 |
| 62 | YES1 | 0.91172305 |
| 63 | TRPM7 | 0.90982824 |
| 64 | CDK12 | 0.90033515 |
| 65 | LATS1 | 0.89136346 |
| 66 | PRKCH | 0.88907948 |
| 67 | CSNK1A1L | 0.88900010 |
| 68 | SGK494 | 0.86396696 |
| 69 | SGK223 | 0.86396696 |
| 70 | CAMK1D | 0.86020356 |
| 71 | MAPK13 | 0.85512100 |
| 72 | PBK | 0.83411120 |
| 73 | TBK1 | 0.82644581 |
| 74 | SGK1 | 0.81694991 |
| 75 | PIM2 | 0.81667639 |
| 76 | PDGFRB | 0.77959289 |
| 77 | STK11 | 0.76673373 |
| 78 | SIK1 | 0.76585645 |
| 79 | PRKCE | 0.76420566 |
| 80 | MAPK7 | 0.75944682 |
| 81 | FGFR4 | 0.75215132 |
| 82 | DDR2 | 0.72819324 |
| 83 | PKN1 | 0.72108940 |
| 84 | ERN1 | 0.71427545 |
| 85 | MTOR | 0.71107740 |
| 86 | CDK5 | 0.69823277 |
| 87 | PIK3CA | 0.69484709 |
| 88 | CAMK4 | 0.68879032 |
| 89 | TTN | 0.68177550 |
| 90 | MINK1 | 0.67941777 |
| 91 | ROCK1 | 0.67710109 |
| 92 | JAK1 | 0.66977926 |
| 93 | NTRK1 | 0.66195620 |
| 94 | CAMK2D | 0.65250208 |
| 95 | PDPK1 | 0.65121171 |
| 96 | PRKCQ | 0.64887617 |
| 97 | TIE1 | 0.64688485 |
| 98 | MUSK | 0.64645925 |
| 99 | SIK2 | 0.64525115 |
| 100 | MAPKAPK5 | 0.64288710 |
| 101 | PRKD3 | 0.64093129 |
| 102 | NEK6 | 0.63852661 |
| 103 | CAMK1 | 0.63654547 |
| 104 | TYK2 | 0.62333819 |
| 105 | RPS6KA6 | 0.62128393 |
| 106 | PAK3 | 0.61576591 |
| 107 | FGFR2 | 0.60150381 |
| 108 | SGK2 | 0.59692352 |
| 109 | MYLK | 0.58981766 |
| 110 | PDK1 | 0.58844437 |
| 111 | MST4 | 0.58827330 |
| 112 | PLK2 | 0.58029031 |
| 113 | CSK | 0.57847384 |
| 114 | BCR | 0.57217376 |
| 115 | CDK9 | 0.56360228 |
| 116 | EPHB2 | 0.56289958 |
| 117 | PRKD2 | 0.56209262 |
| 118 | DYRK1A | 0.55058323 |
| 119 | DMPK | 0.54269821 |
| 120 | JAK2 | 0.54029092 |
| 121 | ROCK2 | 0.53780126 |
| 122 | MAPK10 | 0.53775759 |
| 123 | RAF1 | 0.53741881 |
| 124 | IKBKB | 0.53705525 |
| 125 | PAK2 | 0.53610501 |
| 126 | CLK1 | 0.53526373 |
| 127 | GSK3A | 0.53281940 |
| 128 | CAMK1G | 0.52609278 |
| 129 | PTK2 | 0.51625602 |
| 130 | RPS6KC1 | 0.49517368 |
| 131 | RPS6KL1 | 0.49517368 |
| 132 | UHMK1 | 0.48537144 |
| 133 | FGFR3 | 0.48496866 |
| 134 | MAP3K1 | 0.48445168 |
| 135 | CDC42BPA | 0.47114238 |
| 136 | RPS6KA3 | 0.47002999 |
| 137 | DYRK2 | 0.46468227 |
| 138 | MAP3K10 | 0.45441152 |
| 139 | NTRK2 | 0.45359655 |
| 140 | PIK3CG | 0.45002155 |
| 141 | MAP3K3 | 0.43062553 |
| 142 | PRKAA1 | 0.42238209 |
| 143 | MELK | 0.41870865 |
| 144 | RET | 0.40967007 |
| 145 | PRKD1 | 0.40445726 |
| 146 | PTK2B | 0.40082381 |
| 147 | MAPK11 | 0.39927988 |
| 148 | CSNK1G1 | 0.39883585 |
| 149 | CAMK2B | 0.39628011 |
| 150 | PRKAA2 | 0.39605353 |
| 151 | ITK | 0.39209341 |
| 152 | OXSR1 | 0.37870794 |
| 153 | MAPKAPK2 | 0.35606404 |
| 154 | MARK3 | 0.34085373 |
| 155 | CSNK1G3 | 0.33947001 |
| 156 | TNK2 | 0.33520866 |
| 157 | ABL1 | 0.33166833 |
| 158 | PTK6 | 0.33018279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.43772204 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.83029441 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01308181 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98284157 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.80077540 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 1.71647155 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67095077 |
| 8 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65519004 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58321263 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54015884 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.53203459 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.52484983 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 1.50005462 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.47660054 |
| 15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.42536737 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39291051 |
| 17 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.37945016 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36674256 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.34356416 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32953435 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.32630125 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.31235582 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.30824872 |
| 24 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.30475831 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28879065 |
| 26 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28739637 |
| 27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28443499 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.28421328 |
| 29 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27704299 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24850874 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23980859 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23319217 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22945289 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.22655459 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.22435938 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22001661 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.21784125 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21650623 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 1.18349646 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.17529074 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16761342 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16754259 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16143552 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.15596169 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.15255503 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14302362 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.13665098 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13664889 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.13279240 |
| 50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13101235 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.11767907 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11462767 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10900998 |
| 54 | Malaria_Homo sapiens_hsa05144 | 1.10891636 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.08830655 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.08474123 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 1.07104799 |
| 58 | Prostate cancer_Homo sapiens_hsa05215 | 1.06020820 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 1.05318833 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05139944 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.03362324 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01913118 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01222143 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00663250 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99291207 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.98888365 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98155938 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.97843001 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97792309 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.97464761 |
| 71 | Salivary secretion_Homo sapiens_hsa04970 | 0.96704925 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.95176603 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94994299 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92435290 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.91440568 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90894384 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.90608030 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89789592 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.89693110 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.89105579 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88999903 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88402379 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.87719478 |
| 84 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.87293699 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86187616 |
| 86 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84430432 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.83182266 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.82562800 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81643070 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.81483132 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80659007 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80515621 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80307265 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.80083541 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80030744 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.79534370 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79175884 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78220187 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.77316660 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76882500 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.76535707 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75076687 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73823505 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72943748 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72215511 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71556423 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71284386 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.71254567 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71214142 |
| 110 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71148909 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70840636 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70191384 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70108950 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69774018 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68914343 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67591698 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67373927 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.67313382 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66904570 |
| 120 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66694433 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65953893 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65861709 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63952644 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62222525 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.61811616 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61680975 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61218157 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60500011 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.60303954 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.59925518 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59618248 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59379068 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.57605621 |
| 134 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55849178 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.55170513 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54150493 |
| 137 | Apoptosis_Homo sapiens_hsa04210 | 0.51960364 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51926629 |
| 139 | Hepatitis B_Homo sapiens_hsa05161 | 0.51658072 |
| 140 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51241811 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50817189 |
| 142 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50804113 |
| 143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50505332 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50498495 |
| 145 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50076103 |
| 146 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50075647 |
| 147 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50002536 |
| 148 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49641508 |
| 149 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49538256 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48895447 |
| 151 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47972993 |
| 152 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47904794 |
| 153 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47144315 |
| 154 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46747126 |
| 155 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46020805 |
| 156 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45793841 |
| 157 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45668871 |
| 158 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45350118 |
| 159 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45189864 |
| 160 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44556087 |

